Strides Acquires 18 ANDAs From Pharmaceutics
Deal Also Includes Exclusive Rights To Levothyroxine Candidate
Strides has acquired 18 ANDAs from Pharmaceutics International, as well as exclusive marketing rights to a levothyroxine sodium candidate. Through this agreement, the Indian company plans to expand its niche offerings.
